| Compound Information | SONAR Target prediction | | Name: | ESTRADIOL CYPIONATE | | Unique Identifier: | SPE01500283 | | MolClass: | Checkout models in ver1.5 and ver1.0 | | Molecular Formula: | | | Molecular Weight: | 360.276 g/mol | | X log p: | 7.388 (online calculus) | | Lipinksi Failures | 1 | | TPSA | 26.3 | | Hydrogen Bond Donor Count: | 0 | | Hydrogen Bond Acceptors Count: | 3 | | Rotatable Bond Count: | 5 | | Canonical Smiles: | CC12CCC3C(CCc4cc(O)ccc34)C1CCC2OC(=O)CCC1CCCC1 | | Source: | semisynthetic | | Therapeutics: | estrogen |
| Species: |
4932 |
| Condition: |
PMR1 |
| Replicates: |
2 |
| Raw OD Value: r im |
0.5792±0.00615183 |
| Normalized OD Score: sc h |
1.0105±0.0100604 |
| Z-Score: |
0.4775±0.457254 |
| p-Value: |
0.650326 |
| Z-Factor: |
-7.47233 |
| Fitness Defect: |
0.4303 |
| Bioactivity Statement: |
Nonactive |
| Experimental Conditions | | | Library: | SPECMTS3 | | Plate Number and Position: | 18|B5 | | Drug Concentration: | 50.00 nM | | OD Absorbance: | 600 nm | | Robot Temperature: | 25.50 Celcius | | Date: | 2008-07-04 YYYY-MM-DD | | Plate CH Control (+): | 0.042874999999999996±0.00160 | | Plate DMSO Control (-): | 0.5567500000000001±0.02378 | | Plate Z-Factor: | 0.8634 |
|  png
ps
pdf |
| 4103527 |
(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) octadecanoate |
| 4474060 |
(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) undecanoate |
| 4630920 |
(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)
3-cyclohexylpropanoate |
| 5702051 |
[(13S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]
3-cyclopentylpropanoate |
| 6713666 |
[(8R,9R,13R,14R,17R)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-
yl] 3-cyclopentylpropanoate |
| internal high similarity DBLink | Rows returned: 3 | |
| active | Cluster 13982 | Additional Members: 12 | Rows returned: 4 | |
|
